Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for improving inclusion performance of a pharmaceutical adjuvant beta-cyclodextrin

A technology of excipient package and cyclodextrin, which is applied in the direction of pharmaceutical formulations, organic active ingredients, medical preparations of non-effective ingredients, etc., can solve the problem of insufficient stability of inclusion compounds, low inclusion rate, and low inclusion rate of cyclodextrin and other problems, to achieve the effect of improving inclusion performance and inclusion rate

Active Publication Date: 2017-10-24
广东省药品检验所 +1
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, at present, there are many manufacturers of pharmaceutical excipient β-CD, and the production process is different. During the production process of β-CD, it mainly contains a small amount of α, γ-cyclodextrin impurities, which will affect the inclusion rate. , and the current methods for preparing inclusion compounds mainly include grinding method and saturated solution method. The inclusion compound prepared by grinding method is not stable enough and the inclusion rate is low, while the saturated solution method usually uses a more polar substance as a solvent , generally water is used as the solvent, and the prepared inclusion compound is not high. There are two reasons, ① the raw material β-cyclodextrin has a small amount of impurities; ② the process of combining cyclodextrin with the drug, due to the , the solvent occupies the inner cavity of the β-cyclodextrin. During the stirring process, the drug molecules cannot quickly enter the inner cavity of the β-cyclodextrin, which lacks a driving force, resulting in a low inclusion rate of the cyclodextrin.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for improving inclusion performance of a pharmaceutical adjuvant beta-cyclodextrin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] (1) Recrystallize the β-cyclodextrin produced from source A with purified water, dry at 60°C for 12 hours, and set aside; (2) Use a saturated solution method with a mixed solvent (water:[EMIM]Cl=9.5:0.5) After preparing 27mL of the saturated solution of β-cyclodextrin purified from source A, add the drug naproxen, wherein the drug naproxen and the purified β-cyclodextrin from source A are in a solid-to-solid molar ratio of 1:3 at 70 The clathrate was prepared under the condition of stirring at ℃ for 2 h; (3) The inclusion rate of the clathrate was measured by ultraviolet spectrophotometry, and the inclusion effect of the clathrate before and after purification was compared.

Embodiment 2

[0018] (1) Purify the β-cyclodextrin produced by source A with ethanol, dry it at 60°C for 12 hours, and set aside; (2) Use a saturated solution method, use 27 mL of a mixed solvent (water:[EMIM]Cl=9:1) After preparing the saturated solution of β-cyclodextrin purified from source A, add the drug naproxen, wherein the drug naproxen and the purified β-cyclodextrin from source A are prepared at a solid-to-solid molar ratio of 1:3 at 70°C The clathrate was prepared under the condition of stirring for 2 hours; 3) The inclusion rate of the clathrate was measured by ultraviolet spectrophotometry, and the inclusion effect of the clathrate before and after purification was compared.

Embodiment 3

[0020] (1) Purify the β-cyclodextrin produced by source C with acetone, dry it at 60°C for 12 hours, and set aside; (2) Use a saturated solution method, use 27 mL of a mixed solvent (water:[EMIM]Cl=8:2) After preparing the saturated solution of β-cyclodextrin purified from source C, add the drug naproxen, wherein the drug naproxen and the purified β-cyclodextrin from source C are in a solid-to-solid molar ratio of 1:3 at 70°C The clathrate was prepared under the condition of stirring for 2 hours; (3) The inclusion rate of the clathrate was measured by ultraviolet spectrophotometry, and the inclusion effect of the clathrate before and after purification was compared.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method for improving inclusion performance of an adjuvant is disclosed. The method includes (1) purifying and drying the adjuvant; and (2) adding the adjuvant into a mixed solvent to prepare a saturated solution, adding a medicine with the mole ratio of the medicine to the adjuvant being 1:(3-5), and performing inclusion under stirring at 50-70 DEG C. The method allows the inclusion rate of an inclusion compound prepared by beta-cyclodextrin to be greatly increased and facilitates inclusion performance of the pharmaceutical adjuvant beta-cyclodextrin. Through infrared, ultraviolet and microscopic analysis identification, the structure and performance of the inclusion compound formed by the medicine molecule and the beta-cyclodextrin are not changed. An effective technical guidance for a pharmacy enterprise is provided.

Description

technical field [0001] The invention belongs to the field of pharmaceutical auxiliary materials, and in particular relates to a method for improving the inclusion performance of auxiliary materials β-cyclodextrin. Background technique [0002] β-cyclodextrin (β-CD) is a ring composed of 7 glucose residues combined with β-1,4-glucosidic bonds, which is extracted from starch by microbial enzymes, and has a cone-shaped cylinder. Shaped three-dimensional structure, is a new type of pharmaceutical excipients. Since the outer ring of β-CD is hydrophilic and the inner ring is hydrophobic, it can form inclusion complexes with various compounds through weak van der Waals force, making it stable, solubilizing, slow-release, emulsifying, anti-oxidation, anti-decomposition, and heat preservation , Moisture-proof, and has the function of masking peculiar smell. It is a new type of molecular wrapping material, which can be widely used in the fields of food, chemistry, medicine, agricultu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/61A61K31/192A61K31/216
CPCA61K31/192A61K31/216
Inventor 罗卓雅帅放文林生文王向锋章家伟王淼靳贵英
Owner 广东省药品检验所
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com